Krystal Biotech has received a platform technology designation from the FDA for the genetically modified, nonreplicating herpes simplex virus type...
Gene
Sarepta Therapeutics’ platform technology designation from the FDA for the AAVrh74 viral vector it uses in gene therapy products for...
Louise Rodino-Klapac, PhDSarepta Therapeutics has received platform technology designation from the FDA for bidridistrogene xeboparvovec (also known as SRP-9003)'s rAAVrh74...
The U.S. Food and Drug Administration (FDA) granted platform technology designation to the viral vector used in SRP-9003, an investigational...
The FDA granted Sarepta Therapeutics its first publicly documented Platform Technology Designation for a viral vector, called rAAVrh74, that the...
Sarepta Therapeutics SRPT announced that the FDA has granted platform-technology designation to its viral vector rAAVrh74, used in the investigational gene...
OXB OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for...
Adeno-associated virus (AAV) vector-based gene therapy represents a revolutionary therapeutic approach that scientists develop both in biotechnology and medical fields....
The emergence of gene drive technology shines a new beacon of hope in the battle against malaria, particularly with the...
CRISPR-directed gene edition events in the yellow locus. Credit: The CRISPR Journal (2024). DOI: 10.1089/crispr.2023.0076 Kissing bugs, or triatomine bugs,...
